{"disease":{"id":"systemic-anti-tumor-activity-and-safety-of-the-combination-of-sbrt-and-concurrent-pd-1-blockade-in-metastatic-rcc","name":"systemic anti tumor activity and safety of the combination of sbrt and concurrent pd 1 blockade in metastatic rcc"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06327178","title":"Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}